ML Model for medication prediction

Overview

Development stage

In development or acquisitionSource: a) Pre-deployment – The use case is in a development or acquisition status.

High-impact designation

High-impactSource: a) High-impact

Impact justification

Not reported

Start date

Not reported

Withheld from public reporting

Not reported

Mission

Topic area

Health and Medical

Operational functions

No function tag matched Derived by keyword rules; see methodology

Problem the AI is intended to solve

Pharmacy inventory management

Expected benefits

- Removes ambiguity for users by guiding them through eligibility and next steps.

System outputs

Outliers in drug purchasing history (e.g. sudden increase in purchasing of certain high cost chemotherapeutics) Decreased utilization of certain therapies and increases in the utilization of therapeutic alternatives, whether costly or less costly. Reconcile drug shortage data that may explain purchasing of therapeutic alternatives.

Technology

AI classification

Classical / predictive MLSource: Classical/Predictive Machine Learning: Models trained on data to make predictions or classifications based on identified patterns or relatio…

System name(s)

Not reported

Custom-developed code

Not reported

Public source code

Not reported

Sourcing

How it was built

Not reported

Vendor (as reported)

Not reported

Vendors (standardized)

None on the standard list

A vendor is the supplier named by the agency. It does not identify the underlying model or AI technology.

Data and privacy

Involves PII

Not reported

Privacy Impact Assessment

Not reported

Authorization to Operate

Not reported

Demographic features

Not reported

Training and evaluation data

Not reported

Federal Data Catalog

Not reported

Governance

0 of 8 minimum-practice questions answered. A blank answer means the agency reported nothing; it does not mean the practice is absent.

Potential impacts and how they were identified

Not reported